Target intelligence / Profile preview

Insulin-like growth factor 2 mRNA-binding protein 3 pseudogene 2 (IMP3P2)

Target
IMP3P2
Molecular classification
Other (specifically: pseudogene; not classified as receptor, enzyme, transporter, etc.[2])
01

Overview

IMP3 pseudogene 2 (IMP3P2) is a non-protein-coding genetic element classified as a pseudogene related to the IGF2BP3 gene, which encodes Insulin-like growth factor 2 mRNA-binding protein 3. Unlike its parental gene, IMP3P2 does not produce a functional protein but may influence cellular functions through regulatory RNA mechanisms, such as competing for microRNAs, sequestration of RNA-binding proteins, or generation of regulatory non-coding transcripts. Pseudogenes like IMP3P2 can modulate the transcriptional or post-transcriptional activity of their parental genes, sometimes affecting disease susceptibility or cellular phenotype indirectly, but are not themselves considered direct therapeutic targets.[2][3] Please note that there is no indication from available sources that IMP3P2 is a direct therapeutic target, nor are there any drugs acting upon it, and its main biological relevance is through its potential regulatory effects as a pseudogene[2]. If you intended to search for information about the parental gene (IGF2BP3 / IMP3), that protein *is* a known RNA-binding molecule implicated in cancer and other biological processes[1][3].

Other names
IMP3 pseudogene 2IGF2BP3 pseudogene 2IMP3P2
02

Biological functions

Regulation of parental gene expression (through various non-coding RNA mechanisms such as miRNA responses, competition for RNA-binding proteins, modulation of transcription and translation[2])May act as a competitive endogenous RNA (ceRNA) or generate regulatory non-coding RNAs influencing parental or related gene activity[2]
03

Disease associations

Other (pseudogenes—including IMP3P2—may play a regulatory role in pathogenesis by affecting parental gene expression, but there is no direct evidence implicating IMP3P2 as a driver in major disease categories[2])
04

Biomarkers

Potential as a non-coding RNA biomarker (general for pseudogenes[2]), but there is no specific evidence for IMP3P2

Beyond the preview

Go deeper on Insulin-like growth factor 2 mRNA-binding protein 3 pseudogene 2 (IMP3P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Insulin-like growth factor 2 mRNA-binding protein 3 pseudogene 2 (IMP3P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call